Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis

Wei Zheng1, Hui Li2, Hui Zhang1

  • 11Department of Gastrointestinal Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, 450003 Henan China.

Cancer Cell International
|February 27, 2020
PubMed
Abstract

Insights

Rhophilin Rho GTPase binding protein 1 antisense RNA 1 (RHPN1-AS1) promotes colorectal cancer (CRC) progression by regulating O-GlcNAcylation transferase (OGT) via sponging miR-7-5p. Silencing RHPN1-AS1 inhibits CRC growth, suggesting it as a potential therapeutic target.

Area of Science:

  • Molecular oncology
  • Genetics
  • Cancer biology

Background:

  • Rhophilin Rho GTPase binding protein 1 antisense RNA 1 (RHPN1-AS1) is an emerging oncogene implicated in various cancers.
  • Its specific role in colorectal cancer (CRC) pathogenesis was previously uncharacterized.

Purpose of the Study:

  • To elucidate the molecular function and regulatory mechanisms of RHPN1-AS1 in colorectal cancer progression.
  • To investigate RHPN1-AS1 as a potential therapeutic target for CRC.

Main Methods:

  • Quantitative reverse transcription PCR (qRT-PCR) for RNA expression analysis.
  • Cell proliferation (CCK-8, EdU), apoptosis (flow cytometry), migration, and invasion assays in CRC cells.
  • Xenograft models for in vivo tumor growth assessment.
  • Western blot and mechanistic studies to explore gene interactions.

Main Results:

  • RHPN1-AS1 is significantly overexpressed in CRC cell lines and promotes proliferation, survival, migration, and invasion.
  • RHPN1-AS1 acts as a molecular sponge for miR-7-5p, leading to the upregulation of its downstream target, O-GlcNAcylation transferase (OGT).
  • STAT3 was identified as a transcription factor for RHPN1-AS1, and OGT overexpression reversed the anti-tumor effects of RHPN1-AS1 knockdown.

Conclusions:

  • RHPN1-AS1 promotes colorectal cancer progression by mediating OGT expression through sponging miR-7-5p.
  • RHPN1-AS1 represents a promising therapeutic target for colorectal cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.4K